Cargando…

Delivering a research‐enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program

The last 20 years have seen significant advances in cancer care in Northern Ireland, leading to measureable improvements in patient outcomes. Crucial to this transformation has been an ethos that recognizes the primacy role of research in effecting heath care change. The authors' model of a cro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawler, Mark, Gavin, Anna, Salto‐Tellez, Manuel, Kennedy, Richard D., Van Schaeybroeck, Sandra, Wilson, Richard H., Harkin, Denis Paul, Grayson, Margaret, Boyd, Ruth E., Hamilton, Peter W., McArt, Darragh G., James, Jacqueline, Robson, Tracy, Ladner, Robert D., Prise, Kevin M., O'Sullivan, Joe M., Harrison, Timothy, Murray, Liam, Johnston, Patrick G., Waugh, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864440/ https://www.ncbi.nlm.nih.gov/pubmed/26695702 http://dx.doi.org/10.1002/cncr.29814

Ejemplares similares

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
por: McArt, Darragh G., et al.
Publicado: (2013)

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
por: Dunne, Philip D., et al.
Publicado: (2016)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2015)

Transnational multistakeholder partnerships for sustainable development: Conditions for success
por: Pattberg, Philipp, et al.
Publicado: (2015)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis
por: McCourt, Clare M., et al.
Publicado: (2013)

Let’s Join Forces: Institutional Resilience and Multistakeholder Partnerships in Crises
por: Krlev, Gorgi
Publicado: (2022)

cudaMap: a GPU accelerated program for gene expression connectivity mapping
por: McArt, Darragh G, et al.
Publicado: (2013)

Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption
por: Geaney, Alice, et al.
Publicado: (2023)

NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods
por: Roddy, Aideen C, et al.
Publicado: (2019)

Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
por: Roddy, Aideen C., et al.
Publicado: (2023)

The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
por: Ong, Chee Wee, et al.
Publicado: (2015)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Owens, Alice R., et al.
Publicado: (2021)

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention
por: Buckley, Niamh, et al.
Publicado: (2015)

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer
por: Bradley, Conor A., et al.
Publicado: (2016)

Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned
por: Li, Gerald, et al.
Publicado: (2017)

Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
por: McArt, Darragh G., et al.
Publicado: (2011)

Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
por: Alderdice, Matthew, et al.
Publicado: (2021)

Robustness of differential gene expression analysis of RNA-seq
por: Stupnikov, A., et al.
Publicado: (2021)

Establishing a multistakeholder research agenda: lessons learned from a James Lind Alliance Partnership
por: Jongsma, Karin Rolanda, et al.
Publicado: (2022)

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016)

Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer
por: Riley, J S, et al.
Publicado: (2013)

Constructing a Global Learning Partnership in Physiotherapy: An Ireland–Uganda Initiative
por: O’Sullivan, Cliona, et al.
Publicado: (2017)

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
por: D'Costa, Zenobia C., et al.
Publicado: (2014)

The role of collaborative, multistakeholder partnerships in reshaping the health management of patients with noncommunicable diseases during and after the COVID-19 pandemic
por: Monaco, Alessandro, et al.
Publicado: (2021)

QuPath: Open source software for digital pathology image analysis
por: Bankhead, Peter, et al.
Publicado: (2017)

Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods
por: Murphy, Ross G, et al.
Publicado: (2020)

Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease Progression
por: Stupnikov, Alexey, et al.
Publicado: (2018)

A multistakeholder approach to innovations in NAFLD care
por: Schattenberg, Jörn M., et al.
Publicado: (2023)

Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies
por: Wen, Qing, et al.
Publicado: (2015)

Automated tumor analysis for molecular profiling in lung cancer
por: Hamilton, Peter W., et al.
Publicado: (2015)

Future of the drug label: Perspectives from a multistakeholder dialogue
por: Gispen‐de Wied, Christine C., et al.
Publicado: (2019)

Rare Disease Research Partnership (RAinDRoP): a collaborative approach to identify research priorities for rare diseases in Ireland
por: Somanadhan, Suja, et al.
Publicado: (2020)

A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer
por: Beirne, James P., et al.
Publicado: (2022)

Multistakeholder Participation in Disaster Management—The Case of the COVID-19 Pandemic
por: Panneer, Sigamani, et al.
Publicado: (2021)

A review on individual and multistakeholder fairness in tourism recommender systems
por: Banerjee, Ashmi, et al.
Publicado: (2023)

Pharmacogenomic‐based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system
por: Subasri, Mathushan, et al.
Publicado: (2021)

Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop
por: Garcia, Jose M., et al.
Publicado: (2022)

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
por: Dunne, Philip D., et al.
Publicado: (2017)

Multistakeholder Perspectives on Maternal Text Messaging Intervention in Uganda: Qualitative Study
por: Ilozumba, Onaedo, et al.
Publicado: (2018)

Multistakeholder Engagement in PCORnet, the National Patient-Centered Clinical Research Network
por: Selby, Joe V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v5tj2n9vlbqs68ftqjh548qpjr